XpresSpa Group Signs Contract with Metropolitan Washington Airports Authority for XpresCheck™ COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport
Retrieved on:
Thursday, February 18, 2021
Transportation in the United States, States of the United States, Aviation, Metropolitan Washington Airports Authority, Port Authority of New York and New Jersey, Foreign trade zones of the United States, Dulles International Airport, Googie architecture, Washington metropolitan area, Charleston International Airport, John F. Kennedy International Airport, Fort Lauderdale–Hollywood International Airport
WASHINGTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (XpresSpa or the Company), a health and wellness company, today announced that it has signed a contract with Metropolitan Washington Airports Authority for XpresCheck COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport.
Key Points:
- WASHINGTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (XpresSpa or the Company), a health and wellness company, today announced that it has signed a contract with Metropolitan Washington Airports Authority for XpresCheck COVID-19 Testing Facilities at Dulles International Airport and Reagan National Airport.
- At Dulles International Airport, XpresCheck will be building a pop-up facility located in the Main International Terminal, pre-security.
- At Reagan National Airport, XpresCheck will be building a pop-up facility in their existingXpresSpalocation at National Hall, pre-security.
- Through its XpresTest, Inc. subsidiary, the Company provides COVID-19 screening and testing under the XpresCheck brand at eight locations in six airports: Denver International Airport, JFK International Airport, Boston Logan International Airport (2), Newark Liberty International Airport (2), Phoenix Sky Harbor International Airport, and Salt Lake City International Airport.